DeepIntent, the leading healthcare advertising technology company built to influence better patient health and business outcomes, revealed new research that illuminates the streaming habits and impact of pharmaceutical advertising on adults over the age of 50. In partnership with Roku, Inc., DeepIntent shared the research last week at the company’s second annual Innovating with Intent event focused on the future of connected TV (CTV) in the pharmaceutical industry.
DeepIntent and Roku Research Reveals 79% of Adults 50+ Stream, are More Amenable to Advertising Than the General Population
